Journal of Diabetes Research / 2016 / Article / Tab 1

Research Article

Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections

Table 1

Baseline characteristics of newly diagnosed and long-standing T2DM patients.

CSII groupMDI3 groupMDI4 group

Nn = 39n = 38n = 39
Ln = 43n = 41n = 43
Age (years)
 N55.10 ± 10.0252.95 ± 9.6352.56 ± 9.97
 L59.68 ± 8.2257.67 ± 10.8258.89 ± 11.85
Men
 N19 (49%)18 (47%)19 (49%)
 L25 (58%)21 (51%)23 (53%)
Duration of diabetes (years)
 NNoNoNo
 L12.34 ± 2.0711.33 ± 1.1413.28 ± 2.54
Body mass index (kg/m2)
 N24.55 ± 2.9025.72 ± 3.6225.03 ± 2.84
 L24.73 ± 3.4325.17 ± 3.2924.66 ± 2.84
HbA1c (%)
 N9.65 ± 1.819.99 ± 1.7510.13 ± 1.93
 L8.38 ± 1.688.18 ± 1.588.66 ± 1.73
Systolic blood pressure (mm Hg)
 N126.77 ± 12.55127.05 ± 16.44131.03 ± 15.56
 L129.12 ± 12.76127.41 ± 15.28132.33 ± 11.17
Diastolic blood pressure (mm Hg)
 N81.10 ± 9.8481.64 ± 10.1581.25 ± 6.78
 L82.72 ± 10.4683.67 ± 11.4183.06 ± 11.10
Fasting plasma glucose (mmol/L)
 N10.47 ± 2.6211.07 ± 3.0111.24 ± 2.94
 L9.32 ± 2.228.66 ± 2.759.56 ± 2.35
Fasting plasma insulin (mU/L)
 N5.58 ± 2.957.40 ± 8.846.79 ± 2.91
 L5.97 ± 2.866.01 ± 4.196.11 ± 3.15
Fasting plasma C-peptide (pmol/L)
 N2.23 ± 0.771.98 ± 1.072.36 ± 1.12
 L1.94 ± 0.602.41 ± 1.112.02 ± 0.62

Data are mean (SD) or (%). N: newly diagnosed T2DM patients group; L: long-standing T2DM patients group.